International journal of molecular sciences
Cure8 research brief
Why This Matters
The paper identifies berberine as an alkaloid that reduced epithelial cell pyroptosis and improved tissue injury in a mouse model of bacterial colitis, suggesting a possible new anti-inflammatory mechanism relevant to IBD research.
Who Should Pay Attention
Researchers in IBD mechanisms and drug discovery, translational scientists, and clinicians following preclinical therapeutic developments.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The study is preclinical (cell culture and mouse infection model). It identifies berberine as a compound that limited epithelial pyroptosis linked to GSDME and reduced inflammation and tissue injury in a bacterial colitis model.
These results point to a potential mechanism (modulation of GSDME-mediated pyroptosis and related signaling) rather than an established IBD treatment. Because this is basic-science work in animals and cells, it does not demonstrate safety or effectiveness in people with Crohn’s disease or ulcerative colitis.
It also used an infectious colitis model (Citrobacter rodentium), which differs from human IBD in important ways. If you’re curious about mechanisms or early-stage therapeutic ideas for intestinal inflammation, this paper suggests berberine or targeting epithelial pyroptosis/GSDME could be worth further study in translational research.
Keep In Mind
Findings are from cell culture and a Citrobacter rodentium mouse model (preclinical); this does not establish safety or efficacy in humans.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationInternational journal of molecular sciences
AuthorsZhang M, Wei S, Luo Z +7 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedJul 29, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: National Natural Science Foundation of China - 82530125; Beijing Natural Science Foundation - 7242239; Beijing Nova Program of Science and Technology - 20240484706
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Targeting carbonic anhydrase IX-mediated ferroptosis by atractylenolide I alleviates DSS-induced colitis in mice
The study identifies a potential new mechanism—blocking ferroptosis via CA9—for reducing intestinal inflammation in a mouse model, which could guide future IBD drug research.
MIT-001, a Mitochondria-Targeted ROS Scavenger, Ameliorates DSS-Induced Colitis and Is Associated with Reduced HMGB1 and IL-1β Expression.
The study presents a mitochondria-targeted compound that reduced necrosis markers, HMGB1, and IL-1β in cell and mouse colitis models, highlighting a potential new pathway for IBD treatment research.
Callistephus A from Callistephus chinensis Alleviates DSS-Induced Ulcerative Colitis and Gut-liver Axis Disruption by Targeting the JAK2/STAT1 Pathway and Remodeling Gut Microbiota.
The study identifies a plant-derived compound that reduced inflammation and liver injury in a mouse model of ulcerative colitis and ties its effects to both JAK2/STAT1 inhibition and changes in the gut microbiota—two...